EVP & Chief Scientific OfficerCIK 0002079962
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 0 | Mayes Patrick AEVP & Chief Scientific Officer | Option exercise · 10b5-1 plan | M | $235K 2,207 sh | Aug 7, 2026 traded Aug 5, 2026 | |
Mayes Patrick AEVP & Chief Scientific Officer |
Option exercise · 10b5-1 plan |
| M |
| — 2,207 sh |
| Aug 7, 2026 traded Aug 5, 2026 |
| 7 | Mayes Patrick AEVP & Chief Scientific Officer | Open-market sale · 10b5-1 plan | SELL | $274K 2,207 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 11 | Mayes Patrick AEVP & Chief Scientific Officer | Tax withholding | F | $41K 350 sh | Jul 7, 2026 traded Jul 2, 2026 |
| 11 | Mayes Patrick AEVP & Chief Scientific Officer | Grant or award | A | — 4,218 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 11 | Mayes Patrick AEVP & Chief Scientific Officer | Open-market sale · 10b5-1 plan | SELL | $24K 255 sh | Dec 12, 2025 traded Dec 11, 2025 |
| 25 | Mayes Patrick AEVP & Chief Scientific Officer | Open-market sale · 10b5-1 plan | SELL | $531K 5,553 sh | Dec 12, 2025 traded Dec 10, 2025 |